Samer Ghostine
Neurological Surgery · Los Angeles, CANPI 1316150600
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $229,427 of the $264,203 with a category attached, or 86.8%. 12 manufacturers reported payments, led by Spineart SA at 59.1% of the total. Reporting peaked in 2022 at $61,768 and has fallen 80.3% since, to $12,152 in 2025. Among neurological surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 137 payments — averaging $1928.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spineart SA$156K
- Globus Medical$84K
- Spineart USA Inc$19K
- Boston Scientific$2K
- Abbott$2K
- Nevro Corp.$641
- plus $1K from 6 others
What the payments were for
- Royalty or licence$229,42787%
- Consulting fees$12,5005%
- Travel & lodging$11,3044%
- Food & beverage$10,9724%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spineart SA | 10 | $156,158 |
| Globus Medical | 39 | $83,670 |
| Spineart USA Inc | 26 | $18,681 |
| Boston Scientific | 17 | $1,968 |
| Abbott | 21 | $1,928 |
| Nevro Corp. | 7 | $641 |
| Integra Lifesciences Corporation | 3 | $414 |
| Medtronic | 9 | $326 |
| Highridge Medical LLC | 1 | $146 |
| Aesculap, Inc. | 1 | $106 |
| Johnson & Johnson | 1 | $103 |
| Nalu Medical, Inc. | 2 | $62 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Perla C Post$60,902
- Extreme Angle Cervical Plate$46,321
- RESONATE$36,350
- ROMEO 2 - CROSSLINK$33,652
- PERLA C - CERVICAL POSTERIOR FIXATION$31,458
- PERLA C$30,146
- Perla TL$8,573
- Scarlet AL-T$4,768
- Proclaim Family of SCS IPGs$1,325
- GENERAL PAIN MANAGEMENT$665
- WaveWriter Alpha Prime 16$508
- Excelsius - GPS$423
- CODMAN CERTAS$336
- CUSA CLARITY$336
- CODMAN HAKIM$336
- DURASEAL EXACT SPINAL SEALANT SYSTEM$336
- Senza$246
- Biomet SpinalPak Non-invasive Spine Fusion Stimulator System$146
- INCEPTIV$145
- Omnia$120
How this compares
$264,203 in reported general payments places this provider in the 90th percentile of 773 neurological surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurological surgery in Los Angeles
- Larry KhooLos Angeles$2.8M
- Aaron Cohen-GadolLos Angeles$1.3M
- Geoffrey ColbyLos Angeles$1.1M
- Langston HollyLos Angeles$846K
- Linda LiauLos Angeles$783K
- Adam MamelakLos Angeles$678K
- Martin PhamLos Angeles$596K
- Carl LauryssenLos Angeles$571K
- Vivek MehtaLos Angeles$442K
- Patrick HsiehLos Angeles$345K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.